Suchergebnisse - "Motoi, Noriko"

PubPharm (123)

1

Prognostic Impact of Tumor Doubling Time in Patients with Metachronous Lung Cancer

enthalten in: World journal of surgery | 2019

von Asakura, K. | Yoshida, Y. | Sakurai, H. | +3

2

A Minimum Of 100 Tumor Cells in a Single Biopsy Sample Is Required to Assess Programmed Cell Death Ligand 1 Expression in Predicting Patient Response to Nivolumab Treatment in Nonsquamous Non-Small Cell Lung Carcinoma

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2019

von Naito, T. | Udagawa, H. | Sato, J. | +15

3

Prognostic Impact of Tumor Doubling Time in Patients with Metachronous Lung Cancer

enthalten in: World journal of surgery | 2019

von Asakura, K. | Yoshida, Y. | Sakurai, H. | +3

4

Prognostic Impact of Tumor Doubling Time in Patients with Metachronous Lung Cancer

enthalten in: World journal of surgery | 2019

von Asakura, K. | Yoshida, Y. | Sakurai, H. | +3

5

Trimodality therapy for superior sulcus tumour : experience of a single institution over 19 years

enthalten in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery | 2019

von Uchida, S. | Yoshida, Y. | Ohe, Y. | +6

6

Large pulmonary sclerosing pneumocytoma with massive necrosis and vascular invasion : a case report

enthalten in: Oxford medical case reports | 2019

von Sakai, T. | Miyoshi, T. | Umemura, S. | +9

7

Cryobiopsy during flex-rigid pleuroscopy : an emerging alternative biopsy method in malignant pleural mesothelioma. A comparative study of pathology

enthalten in: Japanese journal of clinical oncology | 2019

von Nakai, T. | Matsumoto, Y. | Sasada, S. | +4

8

Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden : A case report

enthalten in: Thoracic cancer | 2019

von Naito, T. | Umemura, S. | Nakamura, H. | +11

9

Immunocytochemistry for predictive biomarker testing in lung cancer cytology

enthalten in: Cancer cytopathology | 2019

von Jain, D. | Nambirajan, A. | Borczuk, A. | +11

CommentIn: Cancer Cytopathol. 2019 May;127(5):278-280. - PMID 31050221

10

Tumor expression and usefulness as a biomarker of programmed death ligand 1 in advanced non-small cell lung cancer patients with preexisting interstitial lung disease

enthalten in: Medical oncology (Northwood, London, England) | 2019

von Shibaki, R. | Murakami, S. | Matsumoto, Y. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]